🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The aim of this study is to determine the maximal tolerated dose level of l...
Status
Completed
Location
Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie
Start Date
2008-10
Trial ID
NCT00738829
Treatments Being Tested
This Phase I, open-label, dose-finding, multicenter study is designed to de...
Status
Completed
Location
GSK Investigational Site
Start Date
2014-11-13
Trial ID
NCT02215096
Treatments Being Tested
This is a multi-center Phase I/II clinical trial of GTB-3550 (CD16/IL-15/CD...
Status
Terminated
Location
Masonic Cancer Center, University of Minnesota
Start Date
2020-01-01
Trial ID
NCT03214666
Treatments Being Tested
The study is being performed to assess the MTD, pharmacokinetics (PK), safe...
Status
Terminated
Location
National Taiwan University Hospital
Start Date
2017-07-18
Trial ID
NCT03246854
Treatments Being Tested
This study is divided into two parts; Part 1 of the study is a dose escalat...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-03-28
Trial ID
NCT01587703
Treatments Being Tested
The purpose of this study is to determine a maximum tolerated dose and/or r...
Status
Completed
Location
Dana Farber Cancer Institute SC (2)
Start Date
2012-04-20
Trial ID
NCT01468688
This is an open-label, multicenter, dose-escalation and expansion Phase Ib ...
Status
Completed
Location
UCLA Cancer Center
Start Date
2016-01-07
Trial ID
NCT02650713
Treatments Being Tested
The purpose of this study is to determine the maximum tolerated dose (MTD) ...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2016-03
Trial ID
NCT02525029
Treatments Being Tested
The use of multiple drugs in a single clinical trial or as a therapeutic st...
Status
Completed
Location
Centre Hospitalier de Bretagne Sud - HÔPITAL DU SCORFF
Start Date
2013-10
Trial ID
NCT02022098
Treatments Being Tested
This study is to evaluate the safety, pharmacokinetics, and preliminary ant...
Status
Recruiting
Location
Fudan University Shanghai Cancer Center
Start Date
2024-01-02
Trial ID
NCT06950086
Treatments Being Tested